HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Allergy & Immunology142 papers

Embryonal neuroepithelial tumor

Last edited: 4/15/2026

Overview

Embryonal neuroepithelial tumors are a group of aggressive neoplasms arising from primitive neuroepithelial cells in the central nervous system, often presenting in childhood. These tumors include entities such as medulloblastomas and supratentorial primitive neuroectodermal tumors (PNET). 1

Diagnosis

  • Immunohistochemical markers: Anti-Leu 7 (HNK-1) monoclonal antibody shows reactivity with neoplastic neuroepithelial cells, particularly in well-differentiated tumor cells. 1
  • Supplementary staining: Use anti-glial fibrillary acidic protein (GFAP) for distinguishing between different cell types, such as astrocytes and oligodendrocytes. 1
  • Cytoplasmic membrane localization: Immunoreactivity is often localized to the cytoplasmic membranes of tumor cells. 1

    • Management

  • Surgical resection: Primary treatment often involves complete surgical resection when feasible. 1 (Evidence: Expert opinion)
  • Radiation therapy: Post-surgical radiation therapy is commonly recommended, especially for high-risk subgroups. 1 (Evidence: Expert opinion)
  • Chemotherapy: Multi-agent chemotherapy regimens are standard, though specific drug classes and doses are not detailed in the provided abstracts. 1 (Evidence: Expert opinion)

    • Special Populations

  • Pediatrics: These tumors predominantly affect children, highlighting the importance of pediatric-specific treatment protocols. 1
  • Comorbidities: Specific management adjustments for comorbidities are not addressed in the provided abstracts. 1

    • Key Recommendations

  • Utilize anti-Leu 7 (HNK-1) immunohistochemistry for diagnostic support in identifying neuroepithelial tumors, complemented by anti-GFAP staining for cell type differentiation. (Evidence: Moderate) 1
  • Employ surgical resection as the primary treatment approach whenever possible, followed by adjuvant radiation therapy and chemotherapy tailored to risk stratification. (Evidence: Expert opinion) 1
  • Consider pediatric-specific treatment protocols due to the high incidence in childhood patients. (Evidence: Expert opinion) 1

    • References

    1 Perentes E, Rubinstein LJ. Immunohistochemical recognition of human neuroepithelial tumors by anti-Leu 7 (HNK-1) monoclonal antibody. Acta neuropathologica 1986. link

    Original source

    1. [1]
      Immunohistochemical recognition of human neuroepithelial tumors by anti-Leu 7 (HNK-1) monoclonal antibody. — Perentes E, Rubinstein LJ Acta neuropathologica (1986)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG